Extra-adrenal pheochromocytoma.
Whalen RK, Althausen AF, Daniels GH.
J Urol. 1992 Jan;147(1):1-10. doi: 10.1016/s0022-5347(17)37119-7.
Pheochromocytoma: presentation, diagnosis and treatment.
Reisch N, Peczkowska M, Januszewicz A, Neumann HP.
J Hypertens. 2006 Dec;24(12):2331-9. doi: 10.1097/01.hjh.0000251887.01885.54.
Phaeochromocytoma.
Lenders JW, Eisenhofer G, Mannelli M, Pacak K.
Lancet. 2005 Aug 20-26;366(9486):665-75. doi: 10.1016/S0140-6736(05)67139-5.
[Pheochromocytoma: diagnosis and treatment].
Rosenthal R, Conen D.
Schweiz Med Wochenschr. 2000 Sep 16;130(37):1298-304.
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.
Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan.
Endocr Relat Cancer. 2014 May 6;21(3):405-14. doi: 10.1530/ERC-13-0494. Print 2014 Jun.
Diagnosis and management of pheochromocytoma.
Kenady DE, McGrath PC, Sloan DA, Schwartz RW.
Curr Opin Oncol. 1997 Jan;9(1):61-7. doi: 10.1097/00001622-199701000-00010.
Phaeochromocytoma and paraganglioma.
Tarling JA, Kumar R, Ward LJ, Boot C, Wassif WS.
J Clin Pathol. 2024 Jul 18;77(8):507-516. doi: 10.1136/jcp-2023-209234.
[Pheochromocytoma--rare and often undiagnosed condition].
Manhem P, Wahrenberg H.
Lakartidningen. 2002 Mar 19;99(14):1585-9.
VHL disease.
Barontini M, Dahia PL.
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):401-13. doi: 10.1016/j.beem.2010.01.002.
[Phaeochromocytoma and paraganglioma].
Cornu E, Belmihoub I, Burnichon N, Grataloup C, Zinzindohoué F, Baron S, Billaud E, Azizi M, Gimenez-Roqueplo AP, Amar L.
Rev Med Interne. 2019 Nov;40(11):733-741. doi: 10.1016/j.revmed.2019.07.008. Epub 2019 Sep 4.
